Search by Drug Name or NDC

NDC 00409-1312-36 Hydromorphone Hydrochloride 2 mg/mL Details

Hydromorphone Hydrochloride 2 mg/mL

Hydromorphone Hydrochloride is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is HYDROMORPHONE HYDROCHLORIDE.

MedlinePlus Drug Summary

Hydromorphone injection is used to relieve pain. Hydromorphone injection is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

Related Packages: 00409-1312-36
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Hydromorphone Injection

Product Information

NDC	00409-1312
Product ID	0409-1312_f699ac2c-1705-496e-a8ee-5802d2c2515b
Associated GPIs	65100035102010
GCN Sequence Number	078730
GCN Sequence Number Description	hydromorphone HCl CARTRIDGE 2 MG/ML INJECTION
HIC3	H3A
HIC3 Description	OPIOID ANALGESICS
GCN	45115
HICL Sequence Number	001695
HICL Sequence Number Description	HYDROMORPHONE HCL
Brand/Generic	Generic
Proprietary Name	Hydromorphone Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	HYDROMORPHONE HYDROCHLORIDE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Active Ingredient Strength	2
Active Ingredient Units	mg/mL
Substance Name	HYDROMORPHONE HYDROCHLORIDE
Labeler Name	Hospira, Inc.
Pharmaceutical Class	Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA Schedule	CII
Marketing Category	NDA
Application Number	NDA200403
Listing Certified Through	2024-12-31

Package

NDC 00409-1312-36 (00409131236)

Pricing Information	N/A
NDC Package Code	0409-1312-36
Billing NDC	00409131236
Package	10 SYRINGE in 1 CELLO PACK (0409-1312-36) / 1 mL in 1 SYRINGE (0409-1312-16)
Marketing Start Date	2021-02-01
NDC Exclude Flag	N